神经调节设备市场：依细分市场划分的规模、占有率、法规、偿付、程序、到2033年的预测

神经调节器是透过调节神经系统活动来治疗各种神经和精神疾病的医疗器材。神经调节剂透过向神经系统的目标区域提供电或磁刺激来发挥作用。它为神经和精神疾病（例如药物和手术）的传统治疗提供了替代方案。深部脑部刺激器（DBS）、胃电刺激器（GES）、导极、荐神经刺激器（SNS）、脊髓刺激器（SCS）、週边神经刺激器（PNS）、迷走神经刺激器（VNS）等包含在此类别中。

由于神经系统疾病的高盛行率影响着人口老化，这庞大的老年人口基数是神经调节市场的主要驱动力。

本报告深入探讨了全球神经调节剂市场，包括竞争格局、SWOT 分析、到2033年的市场预测以及区域和国家趋势。

目录

目前已上市的神经调节剂及竞争状况

• 对主要产业趋势的见解
• 2015年至2033年神经调节剂各细分市场的市场总收入与市场前景
• 有关单位数量、平均售价和市场价值的详细资料

全球、区域与国家见解

• 神经调节剂市场的 SWOT 分析
• 神经调节剂市场的竞争动态洞察与趋势
• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技的监管状况

Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

Neuromodulation devices are medical devices that are used to treat various neurological and psychiatric disorders by modulating the activity of the nervous system. Neuromodulation Devices work by delivering electrical or magnetic stimulation to targeted areas of the nervous system. Neuromodulation devices offer an alternative to traditional treatments for neurological and psychiatric disorders, such as medications and surgery. Deep brain stimulators (DBS), gastric electric stimulators (GES), leads, sacral nerve stimulators (SNS), spinal cord stimulators (SCS), peripheral nerve stimulators (PNS) and vagus nerve stimulators (VNS) are the segments covered under this category.

Due to the large prevalence of neurological conditions impacting the aging population, this huge geriatric population base is a large driver of the neuromodulation market.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neuromodulation Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Neuromodulation Devices market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Neuromodulation Devices market.
• Competitive dynamics insights and trends provided for Neuromodulation Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, LivaNova Plc, Nevro Corp, AirLife, Beijing Pins Medical Co Ltd, Curonix LLC, Laborie Medical Technologies Inc, Bioness Inc, Avanos Medical Inc, IntraPace Inc, B. Braun Melsungen AG, Axonics Inc, NeuroPace Inc, Xavant Technology (Pty) Ltd, ReShape Lifesciences Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Neuromodulation Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Neuromodulation Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neuromodulation Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Neuromodulation Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.